Application | Comment | Organism |
---|---|---|
additional information | pulmonary vascular and airway diseases in which arginase activity is increased are associated with decreased NO production and reduced smooth muscle relaxation | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Nomega-hydroxy-nor-L-arginine | nor-NOHA; nor-NOHA | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | O08701 | Sprague-Dawley rat, fetus, newborn, adult | - |
Rattus norvegicus | P07824 | Sprague-Dawley rat, fetus, newborn, adult | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
bronchus | - |
Rattus norvegicus | - |
lung | developmental changes in arginase expression and activity in the lung | Rattus norvegicus | - |
additional information | arginase II is regulated developmentally, and both expression and activity are maximal during fetal life | Rattus norvegicus | - |
pulmonary artery | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-arginine + H2O | - |
Rattus norvegicus | L-ornithine + urea | - |
? |
Synonyms | Comment | Organism |
---|---|---|
arginase | - |
Rattus norvegicus |
arginase I | - |
Rattus norvegicus |
arginase II | - |
Rattus norvegicus |